Hosted on MSN27d
EBS obtains rights to Hikma's Kloxxado naloxone sprayKloxxado is a 8mg naloxone nasal spray product used for the emergency treatment of known or suspected opioid overdoses. Emergent (NYSE:EBS) already sells a 4mg naloxone nasal spray product under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback